Family history and inherited cancer risk consultations across CION centres in Hyderabad · Call 1800 202 8726

CION Cancer Clinics

The five classifications on a genetic test report | CION Cancer Clinics

Every gene test sorts what it finds into one of five boxes: pathogenic, likely pathogenic, uncertain significance, likely benign or benign. Only two of the five usually change screening or treatment. This page explains what each tier means, how a laboratory reaches it, and why only two of the five matter for what happens next. At CION Cancer Clinics in Hyderabad, our oncologists review your family history with you and guide you to the right genetic counselling and testing.

Call 1800 202 8726

Speak to an oncologist

NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating

The short answer

What are the five classifications on a genetic report?

Every inherited gene test report sorts each spelling change it finds into one of five boxes: pathogenic, likely pathogenic, uncertain significance, likely benign or benign. This is not a house style one laboratory invented. It comes from a shared framework that laboratories across the world agreed to use, so that a report from one city can be read and trusted in another.

Why five boxes and not two

A gene test rarely answers a plain yes or no. Most changes sit somewhere between clearly harmful and clearly harmless, and the evidence for any one change can be thin, especially for a change that has never been seen before. Five tiers let a laboratory say honestly how sure it is, rather than forcing a guess into a box that is too confident or too vague.

Only two boxes lead to action

Pathogenic and likely pathogenic are the two results that usually change what happens next, for the person tested and for their relatives. The other three, uncertain significance, likely benign and benign, do not change treatment or screening on their own. Knowing which box your result sits in is the single most useful thing you can take away from this page.

A classification is a laboratory's confidence level. It is not a diagnosis, and it is not a percentage.

The five tiers

What each classification actually says

The wording looks similar from one tier to the next. What it means for you is not.

Pathogenic

The evidence is strong and consistent. This change is known to stop the gene working as it should, and it is accepted as the cause of raised risk in that family.

Likely pathogenic

The evidence points the same way but falls short of certain, often because the change is rare and has not been studied as widely. In practice, doctors act on it in the same way.

Uncertain significance

Often written as VUS. The laboratory has found a genuine spelling difference and simply does not yet have enough evidence to call it either way. It is the box most people misread as a soft positive.

Likely benign

The evidence leans toward harmless, most often because the change turns up too often in people with no cancer history to be the cause of raised risk.

Benign

The evidence is strong that this is an ordinary difference between people, of the kind everyone's genetic code carries by the thousand.

Not sure whether this applies to you?

Ask an oncologist

Behind the report

How a laboratory settles on one of the five

How common is the change

A change seen often in people with no cancer history is unlikely to be the cause of anything. A change never seen before carries more weight.

What it does to the protein

Some changes stop the gene's instruction outright. Others swap one small piece for another and may do very little. Computer models give a first estimate, never the final answer.

What happens in the family

If the change is tracked across relatives who did and did not develop cancer, and it lines up with who was affected, that pattern counts as evidence.

Published laboratory studies

Some changes have already been tested directly in a laboratory dish. That evidence, where it exists, usually carries the most weight of all.

On your report

Words this system uses, in plain language

Variant
Any spelling difference found in the gene, before it is judged harmful or harmless.
Classification
The laboratory's confidence label for that variant, one of the five tiers on this page.
Evidence
Everything the laboratory weighed to reach that label: population data, family pattern, computer prediction and published study.
ACMG/AMP framework
The shared rulebook that most laboratories worldwide use to turn evidence into one of the five tiers, so results are comparable between laboratories.
ClinVar
A public database where laboratories submit their classifications, which is how a counsellor checks whether other laboratories agree.
Reclassification
A later change to a classification as new evidence arrives. It is built into the system, not a sign something went wrong the first time.

Leave a number, we will call you

One field. No form to fill in, and no charge for the call.

Side by side

Which classifications change your care, and which do not

Pathogenic or likely pathogenic Uncertain, likely benign or benign
Relatives can be offered testing for that exact change Relatives are not tested for this finding
Screening may start earlier or more often Routine screening for age and background continues
Some treatment options may open up Treatment is planned on the tumour itself, unaffected
Worth a genetic counsellor's active follow-up Noted in your file in case future evidence changes it

A common confusion

Is 'likely' a percentage on the report?

No. "Likely pathogenic" and "likely benign" are not saying seventy per cent or ninety per cent. They are saying the same direction of evidence as their firmer neighbour, just not yet enough of it to drop the word "likely". Some families read that word as a weaker result and ask for a stronger test. There is no stronger test to ask for. The classification itself is the answer, and it stands until new evidence changes it.

Why the same gene can carry variants in every tier

A single gene, such as one linked to breast or ovarian cancer, can have thousands of different possible spelling changes along its length. Some of those are pathogenic, some are harmless, and many sit in the uncertain tier simply because they are rare enough that nobody has gathered enough evidence yet. The gene name on your report tells you which instruction was checked. The classification tells you what was found in your specific copy of it.

Where this system does not reach

This page describes classification of an inherited change found in a blood or saliva sample. A change found only inside a tumour, and not in the rest of the body, is judged by a different set of rules altogether, because the question being asked is different.

Commonly believed

Four things families assume about the five tiers

"Uncertain significance is a weak positive."

It is not a positive result of any strength. It means the laboratory has not yet gathered enough evidence to call it either way. Treatment and preventive decisions are not based on it.

"Likely pathogenic means the doctors are not sure."

Doctors treat likely pathogenic in the same way as pathogenic. The word "likely" describes the strength of the written evidence, not the confidence of the clinical team.

"Benign means I have no cancer risk at all."

Benign means this particular spelling difference is not the cause of raised risk. It says nothing about the many other things, family history included, that shape a person's overall risk.

"Once it is classified, that is final."

Classifications are reviewed as more families and more laboratories contribute evidence. A tier given today can move, in either direction, which is why your counsellor may contact you again even without a new test.

Questions we are asked

Common questions about variant classification

Why are there five classifications and not just positive or negative?

Because the evidence for most changes is not black and white. Five tiers let a laboratory report honestly how strong its evidence is, instead of forcing every finding into a confident yes or no it cannot support.

Does every laboratory use the same five tiers?

Most laboratories worldwide follow the same shared framework, which is why a report from one centre can usually be understood and trusted by a genetic counsellor somewhere else entirely.

Can two laboratories give the same change different classifications?

Occasionally, usually because one laboratory holds evidence, such as an unpublished family study, that the other does not yet have. Public databases exist precisely so this kind of disagreement can be spotted and resolved.

Which classifications actually change my treatment?

Pathogenic and likely pathogenic are the two that usually change screening, treatment options or advice to relatives. Uncertain, likely benign and benign results do not change your care on their own.

My report says likely pathogenic. Is that as serious as pathogenic?

For planning purposes, yes. Doctors act on a likely pathogenic result the same way they act on a pathogenic one. The difference is in how the evidence is worded, not in what your care team will do.

Can a classification change without me having another test?

Yes. Laboratories periodically re-check older results against new evidence. If your tier changes, the laboratory or your counsellor should contact you, which is why keeping your contact details current with them matters.

Is a benign classification the same as a normal test?

It means this one spelling difference is not the cause of raised risk. Your overall result also depends on whether any other gene changes were found, so read the whole report with your counsellor rather than one line of it.

Who can explain which tier applies to my exact result?

A genetic counsellor or clinical geneticist, working from your full report. What your specific variant means is a question for the counsellor who ordered the test, not something to settle by searching the gene name online.

Your Specialists

Meet CION's oncologists. Bring your family history or genetic report to them.

Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Sources

  1. National Cancer Institute — Genetic Testing for Inherited Cancer Susceptibility Syndromes
  2. MedlinePlus Genetics — What do the results of genetic tests mean?
  3. Cancer Research UK — Inherited cancer genes and increased cancer risk
  4. NHS — Predictive genetic tests for cancer risk genes

This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.

Talk to us

Not sure which tier your report is using?

Send us the classification word printed on your report and we will explain, in plain language, what it does and does not mean for you. One helpline serves every CION centre.

Call 1800 202 8726

Speak to an oncologist

Where to find us

Our centres in and around Hyderabad

Addressed by landmark, because that is how this city navigates. One helpline books a consultation at any of these centres, and your team will tell you where counselling and testing take place.

CION Ameerpet

Beside Blue Fox Hotel, Satyam Theatre Road

Begumpet SR Nagar Punjagutta
CION Kukatpally

Opposite Big Bazaar, Mumbai Highway

KPHB JNTU Bharat Nagar
CION L.B. Nagar

Anu Arcade, next to L.B. Nagar Metro station

Vanasthalipuram Nagole Hayathnagar
CION Tolichowki

Inside Premier Hospital, Khader Bagh Road

Mehdipatnam Attapur Rethibowli
CION Masab Tank

Mahavir Hospital, AC Guards, Lakdikapul

Lakdikapul Khairatabad Basheer Bagh
CION Banjara Hills

Road No. 12

Jubilee Hills Madhapur Film Nagar
CION Kompally

Suchitra Circle, NH-44

Suchitra Circle Alwal Dundigal
CION Balanagar

Balanagar Main Road

Balanagar Fatehnagar Moosapet
CION Siddipet

Lohith Sai Hospital, Shivaji Nagar

Gajwel Husnabad Dubbaka
CION Sangareddy

X Roads, Pothreddipalle

Narayankhed Zaheerabad Patancheru
Explore more

Cancer Genetics Topics

Browse CION’s cancer genetics guide — family history and testing, reading a report, genes and syndromes, family planning, cost and support in Hyderabad. Tap any topic to read more.

This guide: Understanding Your Genetic Test Report

How to read a germline genetic test report The five classifications on a genetic test report 'Pathogenic': what this word on your report means 'Likely pathogenic': how sure is this result? 'Variant of uncertain significance' in a germline report Why a VUS should not change your treatment 'Benign' and 'likely benign': the two calm classifications Variant reclassification: when a genetic result changes years later What to do if you receive a genetic reclassification letter Keeping your genetic report findable for years to come Making sense of the c. and p. notation on your report What the gene name and transcript number on your report mean Heterozygous, homozygous and compound heterozygous, explained Biallelic findings: when both copies of a gene are affected A negative genetic result: what it does and does not rule out Uninformative negative: the genetic result nobody explains True negative or uninformative negative: which one is yours? Secondary and incidental findings: results you were not looking for When your cancer test finds a non-cancer condition When genetic testing shows an unexpected family relationship Low-level mosaic findings on a germline genetic report Clonal haematopoiesis picked up on a genetic test When your genetic report says no reportable variants When a genetic test fails or comes back inconclusive Why two labs can classify the same variant differently Looking up your own variant in ClinVar Should you search for your genetic variant online? Getting the raw data behind your genetic report Getting a genetic report read again, by someone new What a complete genetic test report looks like When a genetic report needs to be corrected Going through a genetic report as a family

Breast, ovarian & multi-organ genes

Call 1800 202 8726Book a consultation
Call now Book free consultation